Gorter A - Search Results

1

Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.

Blom DJ, Goslings WR, De Waard-Siebinga I, Luyten GP, Claas FH, Gorter A, Jager MJ. Blom DJ, et al. Among authors: gorter a. J Interferon Cytokine Res. 1997 Nov;17(11):695-700. doi: 10.1089/jir.1997.17.695. J Interferon Cytokine Res. 1997. PMID: 9402107

2

Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.

Goslings WR, Blom DJ, de Waard-Siebinga I, van Beelen E, Claas FH, Jager MJ, Gorter A. Goslings WR, et al. Among authors: gorter a. Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1884-91. Invest Ophthalmol Vis Sci. 1996. PMID: 8759358

3

Cytokines affect resistance of human renal tumour cells to complement-mediated injury.

Blok VT, Gelderman KA, Tijsma OH, Daha MR, Gorter A. Blok VT, et al. Among authors: gorter a. Scand J Immunol. 2003 Jun;57(6):591-9. doi: 10.1046/j.1365-3083.2003.01265.x. Scand J Immunol. 2003. PMID: 12791098 Free article.

4

A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.

Blok VT, Daha MR, Tijsma O, Harris CL, Morgan BP, Fleuren GJ, Gorter A. Blok VT, et al. Among authors: gorter a. J Immunol. 1998 Apr 1;160(7):3437-43. J Immunol. 1998. PMID: 9531304

5

Immune evasion of tumor cells using membrane-bound complement regulatory proteins.

Gorter A, Meri S. Gorter A, et al. Immunol Today. 1999 Dec;20(12):576-82. doi: 10.1016/s0167-5699(99)01537-6. Immunol Today. 1999. PMID: 10562709 Review.

6

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage.

Blok VT, Daha MR, Tijsma OM, Weissglas MG, van den Broek LJ, Gorter A. Blok VT, et al. Among authors: gorter a. Lab Invest. 2000 Mar;80(3):335-44. doi: 10.1038/labinvest.3780038. Lab Invest. 2000. PMID: 10744069 Free article.

7

Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model.

Gelderman KA, Hakulinen J, Hagenaars M, Kuppen PJ, Meri S, Gorter A. Gelderman KA, et al. Among authors: gorter a. Mol Immunol. 2003 Sep;40(1):13-23. doi: 10.1016/s0161-5890(03)00048-8. Mol Immunol. 2003. PMID: 12909127

8

Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.

Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ. Gorter A, et al. Lab Invest. 1996 Jun;74(6):1039-49. Lab Invest. 1996. PMID: 8667608

9

Cytokine profile of cervical cancer cells.

Hazelbag S, Fleuren GJ, Baelde JJ, Schuuring E, Kenter GG, Gorter A. Hazelbag S, et al. Among authors: gorter a. Gynecol Oncol. 2001 Nov;83(2):235-43. doi: 10.1006/gyno.2001.6378. Gynecol Oncol. 2001. PMID: 11606077

10

Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery.

Giezeman-Smits KM, Gorter A, Nagelkerke JF, van Vlierberghe RL, van Eendenburg J, Eggermont AM, Fleuren GJ, Kuppen PJ. Giezeman-Smits KM, et al. Among authors: gorter a. Immunobiology. 1997 Nov;197(5):429-43. doi: 10.1016/S0171-2985(97)80077-0. Immunobiology. 1997. PMID: 9413744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters